JNJ vs SOLV
By Alex · Tickerpine
Johnson & Johnson vs Solventum Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | SOLV |
|---|---|---|
| Price | $273.14 | $91.61 |
| Market cap | $658.24B | $15.59B |
| P/E ratio | 31.7 | 11.2 |
| ROE | 25.74% | 33.96% |
| Profit margin | 21.48% | 17.26% |
| Revenue growth | 6.60% | 2.20% |
| Dividend yield | 1.96% | — |
| Beta | 0.23 | 0.67 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs SOLV in plain English
- JNJ is the bigger company — about 42.2× the market cap of SOLV.
- SOLV is cheaper on earnings (P/E 11.2 vs 31.7).
- SOLV earns a higher return on equity (34% vs 26%).
- JNJ is growing revenue faster (7% vs 2%).
- JNJ pays a dividend (1.96%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
SOLV return calculator
See what $1,000 in Solventum Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.